Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Nafarelin AcetateExisting use: Endometriosis58.6% AI-predicted activityagainst E. coli12 registered studies
- Goserelin AcetateExisting use: Breast cancer, Breast carcinoma, Carcinoma and 1 more58.5% AI-predicted activityagainst E. coli50+ registered studies
- Doxazosin MesylateExisting use: Benign prostatic hyperplasia, Hypertension, Myocardial infarction58.3% AI-predicted activityagainst E. coli50+ registered studies
- Chlorhexidine GluconateExisting use: Eye infection, Gingivitis, Infection and 2 more58.1% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- Zavegepant HydrochlorideExisting use: Migraine disorder57.8% AI-predicted activityagainst E. coliNo documented evidence found
- Bremelanotide AcetateExisting use: Mental or behavioural disorder, Physiological sexual disorder, Sexual dysfunction57.4% AI-predicted activityagainst E. coli1 registered study
- Trametinib Dimethyl SulfoxideExisting use: Cancer, Cutaneous melanoma, Glioblastoma multiforme and 5 more57.2% AI-predicted activityagainst E. coli16 registered studies
- Degarelix AcetateExisting use: Prostate adenocarcinoma, Prostate cancer, Prostate carcinoma57.2% AI-predicted activityagainst E. coli50+ registered studies
- Cisapride MonohydrateExisting use: Gastrointestinal disease56.3% AI-predicted activityagainst E. coli5 registered studies
- Prazosin HydrochlorideExisting use: Diabetes mellitus, Hypertension56.3% AI-predicted activityagainst E. coli50+ registered studies
- PemigatinibExisting use: Cancer, Cholangiocarcinoma, Neoplasm56.0% AI-predicted activityagainst E. coli50+ registered studies
- AtogepantExisting use: Migraine disorder56.0% AI-predicted activityagainst E. coli36 registered studies
- Dolutegravir SodiumExisting use: HIV infection, HIV-1 infection55.9% AI-predicted activityagainst E. coli50+ registered studies
- Desmopressin AcetateExisting use: Central diabetes insipidus, Diabetes insipidus, Enuresis and 5 more55.8% AI-predicted activityagainst E. coli50+ registered studies
- OxytocinExisting use: Hemorrhage, Uterine Inertia55.8% AI-predicted activityagainst E. coli50+ registered studies
- Cetrorelix AcetateExisting use: Ovulation Inhibition, Positive regulation of ovulation55.7% AI-predicted activityagainst E. coli50+ registered studies
- Setmelanotide AcetateExisting use: Obesity55.6% AI-predicted activityagainst E. coliNo documented evidence found
- OlaparibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 9 more55.6% AI-predicted activityagainst E. coli50+ registered studies
- LurbinectedinExisting use: Cancer, Neoplasm, Small cell lung carcinoma55.4% AI-predicted activityagainst E. coli50+ registered studies
- Ganirelix AcetateExisting use: Female infertility, Positive regulation of ovulation, Reproductive Techniques, Assisted55.4% AI-predicted activityagainst E. coli50+ registered studies
- Icatibant AcetateExisting use: Angioedema, Hereditary angioedema55.2% AI-predicted activityagainst E. coli33 registered studies
- Dihydroergotamine MesylateExisting use: Migraine disorder55.2% AI-predicted activityagainst E. coli21 registered studies
- Triptorelin PamoateExisting use: Central precocious puberty, Metastatic prostate cancer, Neoplasm and 3 more55.2% AI-predicted activityagainst E. coli50+ registered studies
- LypressinExisting use: Vasopressin and analogues55.1% AI-predicted activityagainst E. coli50+ registered studies